ArticleGene therapy2016

Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts.

E Bôle-Richard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.